Page last updated: 2024-08-23

idarubicin and gilteritinib

idarubicin has been researched along with gilteritinib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Altman, JK; Asch, A; Cherry, M; Cooper, BW; Cruz, JC; Gill, SC; Hasabou, N; Hill, JE; James, AJ; Jurcic, JG; Levis, MJ; Lin, TL; Perl, AE; Podoltsev, NA; Pratz, KW; Rich, ES; Schiller, GJ; Wu, R	1

Trials

1 trial(s) available for idarubicin and gilteritinib

Article	Year
Gilteritinib in Combination With Induction and Consolidation Chemotherapy and as Maintenance Therapy: A Phase IB Study in Patients With Newly Diagnosed AML. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023, 09-10, Volume: 41, Issue:26 Topics: Adult; Consolidation Chemotherapy; fms-Like Tyrosine Kinase 3; Humans; Idarubicin; Leukemia, Myeloid, Acute; Mutation; Neoplasm Recurrence, Local; Protein Kinase Inhibitors	2023

Article

Year

Gilteritinib in Combination With Induction and Consolidation Chemotherapy and as Maintenance Therapy: A Phase IB Study in Patients With Newly Diagnosed AML.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023, 09-10, Volume: 41, Issue:26

Topics: Adult; Consolidation Chemotherapy; fms-Like Tyrosine Kinase 3; Humans; Idarubicin; Leukemia, Myeloid, Acute; Mutation; Neoplasm Recurrence, Local; Protein Kinase Inhibitors

2023